An Open-label, Parallel-group, Multi-centre, Phase I/III Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Once-daily Oral Administration of D961H 10 mg and D961H 20 mg in Japanese Paediatric Patients 1 to 14 Years Old With Gastrointestinal Acid Related Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02153398

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:19.548258+00:00

Published At

2017-01-19T00:00:00+00:00

Record Updated At

2017-01-19

Results Posted At

2017-01-19

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Gastric Ulcer (GU)", "Duodenal Ulcer (DU)", "Anastomotic Ulcer (AU)", "Non-erosive Reflux Esophagitis Disease (NERD)", "Reflux Esophagitis (RE)", "Zollinger-Ellison Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-01-19"

protocolSection.identificationModule.nctId

"NCT02153398"

protocolSection.identificationModule.officialTitle

"An Open-label, Parallel-group, Multi-centre, Phase I/III Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Once-daily Oral Administration of D961H 10 mg and D961H 20 mg in Japanese Paediatric Patients 1 to 14 Years Old With Gastrointestinal Acid Related Diseases"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-01-19"

Study condition terms

• Gastric Ulcer (GU) (protocolSection.conditionsModule.conditions)
• Duodenal Ulcer (DU) (protocolSection.conditionsModule.conditions)
• Anastomotic Ulcer (AU) (protocolSection.conditionsModule.conditions)
• Non-erosive Reflux Esophagitis Disease (NERD) (protocolSection.conditionsModule.conditions)
• Reflux Esophagitis (RE) (protocolSection.conditionsModule.conditions)
• Zollinger-Ellison Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.